1 1

Committed to Growth

, 2013

Patterson Companies, Inc. June 2014

Cautionary Language Regarding Forward-looking Statements This presentation contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements are information of a non-historical nature and are subject to risks and uncertainties that are beyond the Company’s ability to control. The Company cautions shareholders and prospective investors that these risk factors, among others, may cause actual results to differ materially from those indicated by the forward-looking statements. For a detailed explanation of the risk factors, please see the Company’s filings with the Securities and Exchange Commission. Also, forward-looking statements are qualified in their entirety by the cautionary language set forth in the Company's filings with the Securities and Exchange Commission. Non-GAAP Financial Data Note that this presentation references adjusted performance results. Management believes that these adjustments provide enhanced comparability to the historical results or a better representation of the current quarter performance.

2

3 3

Key Investment Considerations • Innovative and industry-leading technology

• Best-in-class after-sales support

• Compelling underlying demographic trends

• Diversified, but complementary business mix

• Key strategic vendor partnerships • Strong cash generation capabilities

3

4 4

Connecting expertise to inspired ideas,

products and services

Creating a relevant, memorable difference in the

lives of our clients and their customers

4 4

5 5

Fiscal 2014 - Year in Review Consolidated sales exceed $4 billion, up nearly 12% from fiscal 2013 Acquired National Veterinary Services (NVS) in August 2013, expanding Veterinary footprint internationally Reinforced technology leadership position with Dental customers, ending the year with more than 15,000 North American CEREC users Strengthened Medical business by realigning unit around core assets Raised dividend and executed on share repurchase plan as part of multi-pronged capital allocation strategy Continued to invest in Information Technology platform, creating efficiencies and streamlining businesses

5

6 6

Our Competitive Advantage

Specialized sales force Decentralized structure Technology Full-service support Key strategic partnerships

6

7 7

Our Market: Fiscal 2014

12%

58%

30%

7

33% Dental market share

21% Veterinary market share

15% Medical market share

Shared Characteristics

Innovation Fragmentation Market breakthroughs Technology Low cost

of goods

8

Shaping the Market

1988 First intraoral camera

1990s Electronic order entry

1997 Digital radiography

2000s Expanding the portfolio

2014 Transforming markets through innovation

Revenue: $4.1B $220M $1B $661M $200M

9

Worldwide Demographic Trends

2010

U.S. 40m EU 86m

World 528m

2020

U.S. 53m EU 101m

World 719m

2030

U.S. 70m EU 118m

World 976m

Population Growth: 65+ Age Group

10

11 11

Social Responsibility 11

12 12 Patterson Dental Overview

$2.4 billion annual revenue

12

13

“Number of dentists is not expected to keep up with the nation’s population.”

(National Journal)

65+ Increased need for

dental care

Dental Market Trends

Patterson Dental Markets

Private Practice

International Opportunities

Special Markets

(National/Large Group accounts)

Dental Specialties

(Ortho, Endo, Perio)

Currently have approximately 33% of North American Dental market

14

15 15

World-Class Product Offering

15

16 16

Key Proprietary Products and Strategic Partners

16

17 17 Patterson Veterinary Overview

$1.2 billion annual revenue

17

6% Increase in pet

ownership since 1988 to 62 percent

of U.S. households

(APPA)

$55B Estimated expenditures

by pet owners in 2013, up from $41.2B in 2007

(5% CAGR)

(APPA)

Veterinary Market Trends

18

19 19

Patterson Veterinary Market Size

International Opportunities

Independent Practitioners

Special Markets

(National/Large Group accounts)

Specialties

(Emergency/Hospital)

Currently have approximately 21% of U.S. companion animal market - 42% of UK market

19

20 20

World-Class Product Offering

20

21 21

Key Strategic Partnerships

21

22 22

Increasing Shareholder Value Through Strategic Acquisitions Acquisition of National Veterinary Services (NVS) from Dechra Pharmaceuticals closed August, 2013 Fiscal 2014 contribution: $419.3 million in sales, $0.04 EPS In the short term:

• Run as stand-alone operation • Leverage value-added products and services

Longer term, opportunities to expand further into Western Europe \

22

23 23 Patterson Medical Overview

$479 million annual revenue

23

73% of seniors want to stay in home as long as possible

(AARP survey)

All demographics living

more active lifestyles

Medical Market Trends

24

25 25

Hospital, IDN Acute Care/Hospital

Rehabilitation products and services at nursing home facilities

Long-Term Care

Private and chain Outpatient Clinics

Schools and athletic teams at all levels Sports Medicine

International Opportunities

25

Patterson Medical Core Target Markets

25 Currently have approximately 15% of highly fragmented market

26 26

Clinic Supplies Orthopedic & Splinting

Equipment & Modalities

ADL & Mobility

Vertically integrated to assure quality and continuity of supply

World-Class Product Offering

26

27 27

Vertically integrated to assure quality and continuity of supply

Key Proprietary Products and Strategic Partnerships

27

Our Shared Platform

IT: System reliability and commitment to invest

Logistics: Efficient, consistent, reliable service

Shared Business Services: Scalable, one-stop shop

Patterson Technology Center: Best-in-class customer support

28

29 29

How We’ll Grow • Broadened View of the

Markets • Best-in-Class Client Service • Operational Innovation and

Continuous Improvement

29

30 30 Financial Overview

31 31

Financial Platform Strengths • Strong cash flow enables key investments

• One of sector’s most profitable companies

• Multi-pronged capital allocation strategy

• Conservative, well capitalized balance sheet

• Financial flexibility

31

32 32

Cash Use Priorities

Investments to drive

organic growth

Opportunistic acquisitions/ investments

Continuous dividend growth

Share repurchases

32

33 33

$2,167 $2,236 $2,288 $2,380 $2,382

$644 $675 $735 $755 $1,203 $426

$505 $513 $502

$479

$0

$500

$1,000

$1,500

$2,000

$2,500

$3,000

$3,500

$4,000

$4,500

2010 2011 2012 2013 2014

Dental Veterinary Medical

In millions

$3,237 $3,416 $3,536 $3,637

Sustained Sales Growth During Economic Downturn

33

$4,064

33

34 34

$1.78

$1.89 $1.92

$2.03

$2.10

$1.25

$1.35

$1.45

$1.55

$1.65

$1.75

$1.85

$1.95

$2.05

$2.15

2010 2011 2012 2013 2014

*Diluted EPS

Consistent EPS Growth

34

Fiscal 2014 Performance

35

• Diluted EPS of $2.10 • Includes:

• $0.07 per diluted share reduction from systems investments • $0.04 per diluted share contribution from the NVS acquisition

• Excludes: • $0.13 per share of costs for Medical restructuring

• Adjusted Operating Margin 10.1%

• North American CEREC user base grew in high single digits

• Veterinary sales increased 60% • NVS contributed sales of $419.3 million • U.S. equipment sales grew nearly 24%

• Three consecutive quarters of double-digit growth

Fiscal 2015 Guidance

36

EPS: $2.20-$2.30

Guidance assumptions

• Stable North American and international markets, with conditions similar to fiscal 2014

• No impact from share repurchases that may occur during the fiscal year

• The long-term extension of the $250 million of debt that is due in March

• No material acquisitions during the year

5 Year Financial Objectives

8-12% 4-6% 15%

100%

EPS Growth Organic RevenueGrowth

ROIC Free Cash FlowConversion

2015 - 2019

Aggressive, yet realistic targets

37

38 38

Key Investment Considerations • Innovative and industry-leading technology

• Best-in-class after-sales support

• Compelling underlying demographic trends

• Diversified, but complementary business mix

• Key strategic vendor partnerships • Strong cash generation capabilities

38

39 39

Committed to Growth

, 2013

Patterson Companies, Inc. June 2014